Adamson Muula
Biographic Data
| ID | 6068283 |
|---|---|
| NAME | Adamson Muula |
| GIVEN NAMES | Adamson |
| FAMILY NAME | Muula |
| SIGNATURE | MUULA A |
| AFFILIATIONS | University of Malawi College of Medicine |
| VERIFIED | No |
| TOTAL WORKS | 4 |
| TOTAL CITATIONS | 12 |
| AUTHOR COUNT | 4 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2005 |
| LATEST PUBLICATION YEAR | 2023 |
| H-INDEX | 1 |
Uptake of diabetic retinopathy screening at a secondary level facility in Malawi
Diabetic retinopathy (DR) is a common microvascular complication of long-standing diabetes mellitus (DM). DR screening is a cost-effective intervention for preventing blindness from DR. We conducted a cross-sectional study to investigate the uptake and the predictors of uptake of annual DR screening in an opportunistic DR screening programme at a secondary-level diabetes clinic in Southern Malawi. Consecutive patients were interviewed using a str…
Quantifying the cost of in-kind contributions to a multidonor-funded health research capacity-building programme
INTRODUCTION: There are significant investments in health research capacity development in the 'global-south'. The monetary value of contributions from institutions running these programmes is not known. METHODS: Using the Consortium for Advanced Research Training in Africa (CARTA) as a case study we estimate in-kind contributions made by consortium members. We measured unpaid hours of labour contributed by consortium members and converted this t…
The cost-effectiveness of using results-based financing to reduce maternal and perinatal mortality in Malawi
INTRODUCTION: Results-based financing (RBF) is being promoted to increase coverage and quality of maternal and perinatal healthcare in sub-Saharan Africa (SSA) countries. Evidence on the cost-effectiveness of RBF is limited. We assessed the cost-effectiveness within the context of an RBF intervention, including performance-based financing and conditional cash transfers, in rural Malawi. METHODS: We used a decision tree model to estimate expected …
Expanding Access to Antiretroviral Therapy in Sub-Saharan Africa
We describe a number of pitfalls that may occur with the push to rapidly expand access to antiretroviral therapy in sub-Saharan Africa. These include undesirable opportunity costs, the fragmentation of health systems, worsening health care inequities, and poor and unsustained treatment outcomes. On the other hand, AIDS “treatment activism” provides an opportunity to catalyze comprehensive health systems development and reduce health care inequiti…
Expanding Access to Antiretroviral Therapy in Sub-Saharan Africa
We describe a number of pitfalls that may occur with the push to rapidly expand access to antiretroviral therapy in sub-Saharan Africa. These include undesirable opportunity costs, the fragmentation of health systems, worsening health care inequities, and poor and unsustained treatment outcomes. On the other hand, AIDS “treatment activism” provides an opportunity to catalyze comprehensive health systems development and reduce health care inequiti…
Expanding Access to Antiretroviral Therapy in Sub-Saharan Africa
We describe a number of pitfalls that may occur with the push to rapidly expand access to antiretroviral therapy in sub-Saharan Africa. These include undesirable opportunity costs, the fragmentation of health systems, worsening health care inequities, and poor and unsustained treatment outcomes. On the other hand, AIDS “treatment activism” provides an opportunity to catalyze comprehensive health systems development and reduce health care inequiti…
Quantifying the cost of in-kind contributions to a multidonor-funded health research capacity-building programme
INTRODUCTION: There are significant investments in health research capacity development in the 'global-south'. The monetary value of contributions from institutions running these programmes is not known. METHODS: Using the Consortium for Advanced Research Training in Africa (CARTA) as a case study we estimate in-kind contributions made by consortium members. We measured unpaid hours of labour contributed by consortium members and converted this t…
The cost-effectiveness of using results-based financing to reduce maternal and perinatal mortality in Malawi
INTRODUCTION: Results-based financing (RBF) is being promoted to increase coverage and quality of maternal and perinatal healthcare in sub-Saharan Africa (SSA) countries. Evidence on the cost-effectiveness of RBF is limited. We assessed the cost-effectiveness within the context of an RBF intervention, including performance-based financing and conditional cash transfers, in rural Malawi. METHODS: We used a decision tree model to estimate expected …
Uptake of diabetic retinopathy screening at a secondary level facility in Malawi
Diabetic retinopathy (DR) is a common microvascular complication of long-standing diabetes mellitus (DM). DR screening is a cost-effective intervention for preventing blindness from DR. We conducted a cross-sectional study to investigate the uptake and the predictors of uptake of annual DR screening in an opportunistic DR screening programme at a secondary-level diabetes clinic in Southern Malawi. Consecutive patients were interviewed using a str…
Economics (3 works) · Global Maternal and Child Health (3 works) · Medicine (3 works) · Business (2 works) · Economic growth (2 works) · Environmental health (2 works) · Family medicine (2 works) · Nursing (2 works) · Political science (2 works) · Acute Ischemic Stroke Management (1 works)